LA-Bac8c

• Description :

  LA-Bac8c is a Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties. LA-Bac8c inhibits S. aureus, MRSA, S. epidermidis, E. coli, and P. aeruginosa with MICs of 1, 4, 8, 8, and 8 μg/mL[1].

• UNSPSC :

  12352209

• Target :

  Antibiotic; Bacterial

• Type :

  Peptides

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/la-bac8c.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C([C@@H](NC(CCCC[C@@H]1CCSS1)=O)CCCNC(N)=N)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CC2=CNC3=CC=CC=C23)=O)[C@H](CC)C)=O)C(C)C)=O)CC4=CNC5=CC=CC=C45)=O)[C@H](CC)C

• Molecular Formula :

  C65H102N20O9S2

• Molecular Weight :

  1371.76

• References & Citations :

  [1]Wenya Zhou, et al. Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties. Bioorg Med Chem. 2020 Oct 1;28 (19) :115682.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported